Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-04 · accession 0001209191-23-002052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-05 | 2023-01-04 | KPTI | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $3.27 | -3,922 | 608.6K | -0.6% | -$12.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-04 | S | D | 3,922 | $3.27 | 608,605 | D | — | — |